0000899866-15-000210.txt : 20151215 0000899866-15-000210.hdr.sgml : 20151215 20151215173549 ACCESSION NUMBER: 0000899866-15-000210 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151211 FILED AS OF DATE: 20151215 DATE AS OF CHANGE: 20151215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moriarty John B CENTRAL INDEX KEY: 0001564621 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 151289372 MAIL ADDRESS: STREET 1: ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_145021893919341.xml FORM 4 X0306 4 2015-12-11 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001564621 Moriarty John B ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410 0 1 0 0 EVP & General Counsel Common Stock, par value $.0001 per share 2015-12-11 4 S 0 918 182.65 D 41365 D Common Stock, par value $.0001 per share 2015-12-11 4 S 0 25 185.54 D 41340 D This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $182.00 - $182.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $185.00 - $185.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco, Attorney-in-Fact for John B. Moriarty 2015-12-15